UT Austin Targeted Therapeutic Drug Discovery & Development Program (TTP) - Austin, Texas

Introduction to the UT Austin Targeted Therapeutic Drug Discovery & Development Program (TTP)

The University of Texas at Austin's Targeted Therapeutic Drug Discovery & Development Program (TTP) is a leading research institute located in the heart of Austin, Texas. As a part of the University of Texas's McKnight Department of Chemical Engineering, TTP is dedicated to advancing the field of drug discovery and development through cutting-edge research and innovative technologies. With a focus on targeted therapies, TTP aims to develop novel treatments for complex diseases, including cancer, neurological disorders, and infectious diseases.

Located in the Biomedical Engineering Building, 107 W Dean Keeton St Room 6.202, Austin, TX 78712, TTP is easily accessible by car or public transportation. The building is wheelchair accessible, with a wheelchair accessible entrance and parking lot, making it convenient for visitors with mobility impairments.

Main Services

• Targeted Therapeutic Drug Discovery: TTP offers a range of services focused on the discovery of novel therapeutic compounds, including small molecule and biologic targets.
• Drug Development: The program provides expertise in the development of targeted therapies, from preclinical studies to clinical trials.
• Chemical Biology: TTP's chemical biology team develops novel chemical tools and methods for the discovery and optimization of therapeutic compounds.
• Bioinformatics: The program utilizes bioinformatics tools and expertise to analyze and interpret large datasets, facilitating the discovery of new therapeutic targets.
• Collaborations and Partnerships: TTP fosters collaborations with academia, industry, and government to accelerate the development of targeted therapies.
• Training and Education: The program provides training and education opportunities for students, postdoctoral researchers, and industry professionals, promoting the advancement of the field.

Location and Access

The Biomedical Engineering Building, home to TTP, is located at 107 W Dean Keeton St Room 6.202, Austin, TX 78712. This address is easily accessible by car, with ample parking options available in the surrounding area. Public transportation options, including buses and ride-sharing services, are also readily available.

For those with mobility impairments, the building is wheelchair accessible, with a wheelchair accessible entrance and parking lot. The entrance is located on the north side of the building, and the parking lot is designated for visitors with mobility impairments.

Featured Characteristics

• State-of-the-art research facilities: TTP is equipped with cutting-edge research facilities, including state-of-the-art mass spectrometry, NMR, and X-ray crystallography instruments.
• Expertise in targeted therapies: The program's team of experts has extensive experience in the development of targeted therapies, with a focus on complex diseases.
• Collaborative environment: TTP fosters a collaborative environment, with opportunities for partnerships and collaborations with academia, industry, and government.
• Training and education: The program provides comprehensive training and education opportunities for students, postdoctoral researchers, and industry professionals.
• Research funding: TTP has received significant research funding from government agencies and private organizations, ensuring a strong foundation for research initiatives.

Practical Information

• Phone: 512-223-21085
• Website: pharmacy.utexas.edu
• Email: [[email protected]](mailto:[email protected])
• Hours of Operation: Monday - Friday, 8:00 AM - 5:00 PM
• Address: Biomedical Engineering Building, 107 W Dean Keeton St Room 6.202, Austin, TX 78712

Opinions and Reviews

Unfortunately, TTP has not received any reviews on Google My Business, making it difficult to assess the program's reputation. However, the program's focus on cutting-edge research and innovative technologies, combined with its collaborative environment and training opportunities, suggests a high level of expertise and commitment to advancing the field of targeted therapeutics.

It is essential to note that TTP is a research institute, and as such, its primary focus is on advancing knowledge and understanding in the field of targeted therapeutics, rather than providing direct patient care or treatment services. However, the program's expertise and research initiatives can have a significant impact on the development of novel treatments for complex diseases, ultimately benefiting patients and improving healthcare outcomes.

As with any research institution, it is crucial to evaluate TTP's research initiatives and programs carefully, considering factors such as funding, expertise, and collaboration opportunities. By doing so, researchers, students, and industry professionals can leverage TTP's strengths to advance the field of targeted therapeutics and improve healthcare outcomes.